Investing Acceleration of RAD204 Phase 1 dose escalation trial by admin May 12, 2025 May 12, 2025 Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com previous post Triumph Gold Discovers a New Silver and Gold Vein Showing at the Freegold Mountain Project, Yukon next post House GOP unveils Medicaid work requirements in Trump’s ‘big, beautiful bill’ You may also like Noble Minerals Acquires a Property with Significant Uranium,... January 17, 2025 Empire Metals Limited Announces Conference Presentations in Australia... May 4, 2025 Top 10 Gold-mining Companies (Updated 2024) August 14, 2024 Retraction of Forecast Financial Information Plus Announcement on... October 13, 2024 IEF Applauds UK’s £21.7 Billion Carbon Capture Investment October 8, 2024 New Zealand Government Publishes Its Critical Minerals List... February 3, 2025 Radiopharm achieves Nasdaq listing of ADS November 27, 2024 Danielle DiMartino Booth: US Economy at Precipice —... March 28, 2025 Anteros Identifies High-Grade Copper-Gold Targets at the Strickland... May 21, 2025 BHP and Toyota Australia to Test Electric HiLux... November 2, 2024